Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 7/20 | 0.56 |
| ▸ | MMP12 | P39900 | 1/20 | 0.48 |
| ▸ | CTSL | P07711 | 3/20 | 0.47 |
| ▸ | CTSB | P07858 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | ALPI | P09923 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | XIAP | P98170 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | CTSH | P09668 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2289952 | 1.00 | CTSK (0.56) | CTSKMMP12CTSLCTSBALDH1A1 | |
| SCHEMBL8204879 | 0.89 | CTSK (0.53) | CTSKMMP12CTSLCTSBALDH1A1 | |
| SCHEMBL1838075 | 0.88 | CTSK (0.58) | CTSKCTSLCTSBHDAC3HDAC4 | |
| SCHEMBL9370319 | 0.88 | CTSK (0.58) | CTSKCTSLCTSBHDAC3HDAC4 | |
| SCHEMBL27549298 | 0.88 | CTSK (0.52) | CTSKCTSLCTSBALDH1A1 | |
| SCHEMBL5945552 | 0.88 | CTSK (0.52) | CTSKCTSLCTSBALDH1A1 | |
| SCHEMBL8811765 | 0.87 | MMP12 (0.48) | CTSKMMP12CTSLCTSBALDH1A1 | |
| SCHEMBL11308906 | 0.86 | CTSK (0.51) | CTSKCTSLCTSBALDH1A1 | |
| SCHEMBL2292391 | 0.86 | CTSK (0.56) | CTSKMMP12CTSLCTSBALDH1A1 | |
| SCHEMBL3008826 | 0.86 | CTSK (0.56) | CTSKMMP12CTSLCTSBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4188589-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2023-06-07 | — | — | EP | disclosed |
| EP-4021629-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2022-07-06 | — | — | EP | disclosed |
| WO-2021037703-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2021-03-04 | — | — | WO | disclosed |
| US-10806683-B2 | Encapsulated perfume compositions | GIVAUDAN SA (CH) | 2020-10-20 | — | — | US | disclosed |
| US-10722857-B2 | Encapsulated perfume compositions | GIVAUDAN S.A. (CH) | 2020-07-28 | — | — | US | disclosed |
| US-10537868-B2 | Microcapsules | GIVAUDAN S.A. (CH) | 2020-01-21 | — | — | US | disclosed |
| US-20180185808-A1 | MICROCAPSULES | GIVAUDAN SA (CH) | 2018-07-05 | — | — | US | disclosed |
| US-20180177689-A1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2018-06-28 | — | — | US | disclosed |
| US-20180169603-A1 | IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS | GIVAUDAN S.A. (CH) | 2018-06-21 | — | — | US | disclosed |
| US-8304223-B2 | Isoforms of pig liver esterase | ENZYMICALS AG (DE) | 2012-11-06 | — | — | US | disclosed |
| US-8304223-B2 | Isoforms of pig liver esterase | ENZYMICALS AG (DE) | 2012-11-06 | — | — | US | disclosed |
| US-20110207186-A1 | Isoforms of Pig Liver Esterase | ENZYMICALS AG (DE) | 2011-08-25 | — | — | US | disclosed |
| US-20110207186-A1 | Isoforms of Pig Liver Esterase | ENZYMICALS AG (DE) | 2011-08-25 | — | — | US | disclosed |
| WO-2008116745-A2 | ISOFORMS OF PIG LIVER ESTERASE | EVONIK DEGUSSA GMBH (DE) | 2008-10-02 | — | — | WO | disclosed |
| US-7229817-B2 | Recombinant porcine liver esterases, their use and a method for the production thereof | DEGUSSA AG (DE) | 2007-06-12 | — | — | US | disclosed |
| US-7229817-B2 | Recombinant porcine liver esterases, their use and a method for the production thereof | DEGUSSA AG (DE) | 2007-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207186-A1 | Isoforms of Pig Liver Esterase | CES1, PIGO, PIGS | CTSK 1846/4885MMP12 3188/4885CTSL 1341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.